Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer.
Grosgeorges M, Picque Lasorsa L, Pastor B, Prévostel C, Crapez E, Sanchez C, Frayssinoux F, Jarlier M, Pezzella V, Monard L, Ychou M, Thierry AR, Mazard T, Blache P. Grosgeorges M, et al. Among authors: pastor b. Sci Rep. 2023 Feb 15;13(1):2739. doi: 10.1038/s41598-023-29948-4. Sci Rep. 2023. PMID: 36792801 Free PMC article.
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer.
Parseghian CM, Parikh NU, Wu JY, Jiang ZQ, Henderson L, Tian F, Pastor B, Ychou M, Raghav K, Dasari A, Fogelman DR, Katsiampoura AD, Menter DG, Wolff RA, Eng C, Overman MJ, Thierry AR, Gallick GE, Kopetz S. Parseghian CM, et al. Among authors: pastor b. Clin Cancer Res. 2017 Aug 1;23(15):4146-4154. doi: 10.1158/1078-0432.CCR-16-3138. Epub 2017 Mar 9. Clin Cancer Res. 2017. PMID: 28280091 Free PMC article. Clinical Trial.
Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer.
Thierry AR, Pastor B, Jiang ZQ, Katsiampoura AD, Parseghian C, Loree JM, Overman MJ, Sanchez C, Messaoudi SE, Ychou M, Kopetz S. Thierry AR, et al. Among authors: pastor b. Clin Cancer Res. 2017 Aug 15;23(16):4578-4591. doi: 10.1158/1078-0432.CCR-17-0232. Epub 2017 Apr 11. Clin Cancer Res. 2017. PMID: 28400427 Free PMC article. Clinical Trial.
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.
Thierry AR, El Messaoudi S, Mollevi C, Raoul JL, Guimbaud R, Pezet D, Artru P, Assenat E, Borg C, Mathonnet M, De La Fouchardière C, Bouché O, Gavoille C, Fiess C, Auzemery B, Meddeb R, Lopez-Crapez E, Sanchez C, Pastor B, Ychou M. Thierry AR, et al. Among authors: pastor b. Ann Oncol. 2017 Sep 1;28(9):2149-2159. doi: 10.1093/annonc/mdx330. Ann Oncol. 2017. PMID: 28911069 Free article.
Recent advances in circulating nucleic acids in oncology.
Otandault A, Anker P, Al Amir Dache Z, Guillaumon V, Meddeb R, Pastor B, Pisareva E, Sanchez C, Tanos R, Tousch G, Schwarzenbach H, Thierry AR. Otandault A, et al. Among authors: pastor b. Ann Oncol. 2019 Mar 1;30(3):374-384. doi: 10.1093/annonc/mdz031. Ann Oncol. 2019. PMID: 30753271 Free article. Review.
Quantifying circulating cell-free DNA in humans.
Meddeb R, Dache ZAA, Thezenas S, Otandault A, Tanos R, Pastor B, Sanchez C, Azzi J, Tousch G, Azan S, Mollevi C, Adenis A, El Messaoudi S, Blache P, Thierry AR. Meddeb R, et al. Among authors: pastor b. Sci Rep. 2019 Mar 26;9(1):5220. doi: 10.1038/s41598-019-41593-4. Sci Rep. 2019. PMID: 30914716 Free PMC article. Clinical Trial.
Blood contains circulating cell-free respiratory competent mitochondria.
Al Amir Dache Z, Otandault A, Tanos R, Pastor B, Meddeb R, Sanchez C, Arena G, Lasorsa L, Bennett A, Grange T, El Messaoudi S, Mazard T, Prevostel C, Thierry AR. Al Amir Dache Z, et al. Among authors: pastor b. FASEB J. 2020 Mar;34(3):3616-3630. doi: 10.1096/fj.201901917RR. Epub 2020 Jan 19. FASEB J. 2020. PMID: 31957088 Free article.
Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment.
Pastor B, André T, Henriques J, Trouilloud I, Tournigand C, Jary M, Mazard T, Louvet C, Azan S, Bauer A, Roch B, Sanchez C, Vernerey D, Thierry AR, Adenis A. Pastor B, et al. Mol Oncol. 2021 Sep;15(9):2401-2411. doi: 10.1002/1878-0261.12972. Epub 2021 Jun 22. Mol Oncol. 2021. PMID: 33934494 Free PMC article. Clinical Trial.
81 results